Julien Chongwang

May 27, 2024 | fr.allafrica.com | Julien Chongwang

DOUALA — L'Afrique dispose désormais d'un centre de recherche et de formation en diplomatie scientifique baptisé « Centre de Diplomatie Scientifique pour l'Afrique ». Il a été inauguré le 6 mai 2024 à Kigali, la capitale du Rwanda, au lendemain de la cinquième conférence annuelle du Réseau international en conseil scientifique gouvernemental (INGSA).

May 20, 2024 | scidev.net | Ogechi Ekeanyanwu |Julien Chongwang

[KIGALI] Data generated in the global South has given rise to two approved vaccines against malaria and could this decade lead to a new vaccine for tuberculosis, says Jeremy Farrar, chief scientist at the World Health Organization (WHO). He believes investment in scientific systems is vital to keep this momentum going and to tackle not just infectious diseases but cancer, heart disease, and mental health – all of which are increasingly affecting low- and middle-income countries.

Apr 23, 2024 | fr.allafrica.com | Julien Chongwang

interviewCet article a été produit avec le soutien du Réseau international pour le conseil scientifique aux gouvernements (INGSA). Créé en 2014, l'International Network for Government Science Advice (Réseau international pour le conseil scientifique aux gouvernements - INGSA) encourage la collaboration entre chercheurs et décideurs en vue de l'élaboration de politiques fondées sur des données scientifiques probantes.

Oct 9, 2023 | allafrica.com | Jackie Opara |Ruth Douglas |Julien Chongwang

London/Douala/Lagos — Vaccine developers must share the know-how behind a groundbreaking new malaria jab so it can be rolled out efficiently to poor populations in Africa that need it most, according to a senior malaria advisor to the continent's main healthcare agency. "We need to start having this conversation around tech transfer and IP," said Nicaise Ndembi, advisor to the director general of Africa CDC, based in Addis Ababa, Ethiopia.

Oct 6, 2023 | scidev.net | Ruth Douglas |Julien Chongwang |Jackie Opara

[LONDON/DOUALA/LAGOS] Vaccine developers must share the know-how behind a groundbreaking new malaria jab so it can be rolled out efficiently to poor populations in Africa that need it most, according to a senior malaria advisor to the continent’s main healthcare agency. “We need to start having this conversation around tech transfer and IP,” said Nicaise Ndembi, advisor to the director general of Africa CDC, based in Addis Ababa, Ethiopia.